Our Comments on FDA’s Draft Guidance for Predetermined Change Control for AI/ML Devices
M. Jason Brooke, Esq.*
July 2, 2023
M. Jason Brooke shares his practical and legal concerns with the new draft guidance affecting AI/ML-enabled device software functions, requesting that the Agency ensures clarity and consistency with U.S. regulations and effective FDA policy.